Revised Financial Results for March 31, 2015
With reference to earlier announcement dated May 29, 2015 regarding Financial Results for March 31, 2015, Jagsonpal Pharmaceuticals Ltd has now informed BSE that a typographic error had occurred in Financial Results for the year ended March 31, 2015, and the fallacy has been rectified. The Company has submitted to BSE the rectified document in lieu of already submitted financial result. Board recommends Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2015, inter alia, has recommended a final dividend of Rs. 0.10 per share (2%) subject to approval of the shareholders at the ensuing Annual General Meeting. Financial Results & Auditors Report for March 31, 2015 (Standalone) (Audited)
Jagsonpal Pharmaceuticals Ltd has informed BSE that about the Standalone Financial Results & a copy of the Auditors Report for the period ended March 31, 2015. Board to consider Dividend
Jagsonpal Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 29, 2015 to:1. Consider and Approve the Audited financial results for the quarter/year ended March 31, 2015.2. Recommend dividend, if any, for the year ended March 31, 2015. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Jagsonpal Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Shareholding Pattern For March 31, 2015
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015. Appointment of Woman Director
Jagsonpal Pharmaceuticals Ltd has informed BSE that Mrs. Jasbir Kaur Kochhar has been appointment as woman Director of the Company in terms of compliance of companies Act, 2013 and other provisions if any. Financial Results & Limited Review for Dec 31, 2014 (Standalone)
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014. Shareholding Pattern For December 31, 2014
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014. Financial Results & Limited Review for Sept 30, 2014 (Standalone)
Jagsonpal Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2014.